| Primary |
| Bronchitis |
12.3% |
| Pneumonia |
10.8% |
| Sinusitis |
9.9% |
| Pyrexia |
7.5% |
| Pharyngitis |
7.1% |
| Upper Respiratory Tract Infection |
6.3% |
| Nasopharyngitis |
5.7% |
| Cough |
5.6% |
| Ill-defined Disorder |
5.3% |
| Infection |
4.1% |
| Upper Respiratory Tract Inflammation |
4.0% |
| Hypertension |
3.7% |
| Respiratory Tract Infection |
3.3% |
| Ear Infection |
2.7% |
| Tonsillitis |
2.4% |
| Pneumonia Mycoplasmal |
2.0% |
| Hiv Infection |
1.9% |
| Oropharyngeal Pain |
1.9% |
| Asthma |
1.8% |
| Prophylaxis |
1.8% |
|
| Drug Hypersensitivity |
16.4% |
| Vomiting |
10.5% |
| Drug Ineffective |
8.8% |
| Urticaria |
7.9% |
| Rash |
5.9% |
| Diarrhoea |
5.3% |
| Tinnitus |
4.4% |
| Rhabdomyolysis |
4.2% |
| Malaise |
3.7% |
| Stevens-johnson Syndrome |
3.6% |
| Nausea |
3.5% |
| Weight Decreased |
3.2% |
| Anosmia |
3.1% |
| Hypersensitivity |
3.1% |
| Deafness |
3.0% |
| Interstitial Lung Disease |
3.0% |
| Pyrexia |
3.0% |
| Tremor |
2.7% |
| Death |
2.5% |
| Toxic Epidermal Necrolysis |
2.3% |
|
| Secondary |
| Hiv Infection |
10.5% |
| Drug Use For Unknown Indication |
10.1% |
| Product Used For Unknown Indication |
9.3% |
| Pneumonia |
8.6% |
| Bronchitis |
8.1% |
| Sinusitis |
6.9% |
| Cough |
6.6% |
| Pyrexia |
5.9% |
| Hypertension |
4.0% |
| Nasopharyngitis |
3.9% |
| Infection |
3.7% |
| Upper Respiratory Tract Infection |
3.2% |
| Pharyngitis |
3.0% |
| Foetal Exposure During Pregnancy |
3.0% |
| Infection Prophylaxis |
2.5% |
| Opportunistic Infection Prophylaxis |
2.5% |
| Prophylaxis |
2.4% |
| Ear Infection |
2.0% |
| Mycobacterium Avium Complex Infection |
2.0% |
| Oropharyngeal Pain |
1.9% |
|
| Drug Hypersensitivity |
9.3% |
| Weight Decreased |
9.3% |
| Vomiting |
8.2% |
| Pyrexia |
7.7% |
| Drug Ineffective |
6.4% |
| Stevens-johnson Syndrome |
6.4% |
| Urticaria |
6.4% |
| Rash |
6.1% |
| Uveitis |
5.6% |
| Rhabdomyolysis |
4.0% |
| Shock |
3.7% |
| Sinusitis |
3.7% |
| Pneumonia |
3.5% |
| Nausea |
3.2% |
| Upper Respiratory Tract Infection |
3.2% |
| Tinnitus |
2.9% |
| Diarrhoea |
2.7% |
| Liver Disorder |
2.7% |
| Tremor |
2.7% |
| Tendonitis |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.4% |
| Drug Use For Unknown Indication |
12.9% |
| Hiv Infection |
7.8% |
| Pain |
7.8% |
| Depression |
5.7% |
| Multiple Myeloma |
3.9% |
| Hypertension |
3.8% |
| Asthma |
3.7% |
| Anxiety |
3.7% |
| Prophylaxis |
3.7% |
| Contraception |
3.4% |
| Bronchitis |
3.2% |
| Acne |
2.9% |
| Cough |
2.4% |
| Sinusitis |
2.3% |
| Pneumonia |
2.2% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Nausea |
1.9% |
| Infection |
1.7% |
| Premenstrual Syndrome |
1.6% |
|
| Vomiting |
13.0% |
| Weight Decreased |
12.0% |
| Pulmonary Embolism |
11.3% |
| Pain |
7.0% |
| Weight Increased |
6.1% |
| Ventricular Septal Defect |
6.0% |
| Pneumonia |
5.4% |
| Urinary Tract Infection |
4.8% |
| Pyrexia |
3.9% |
| Rash |
3.1% |
| Anxiety |
3.0% |
| Wheezing |
3.0% |
| Deep Vein Thrombosis |
2.9% |
| Sinusitis |
2.8% |
| Vision Blurred |
2.8% |
| Upper Respiratory Tract Infection |
2.8% |
| Nausea |
2.7% |
| Myocardial Infarction |
2.5% |
| Vertigo |
2.5% |
| Thrombocytopenia |
2.4% |
|
| Interacting |
| Product Used For Unknown Indication |
11.6% |
| Ill-defined Disorder |
10.1% |
| Pneumonia |
7.6% |
| Drug Use For Unknown Indication |
7.1% |
| Tuberculosis |
7.1% |
| Aspergillosis |
6.1% |
| Bronchitis |
6.1% |
| Lung Transplant |
6.1% |
| Upper Respiratory Tract Inflammation |
5.1% |
| Chlamydial Infection |
4.5% |
| Cellulitis |
4.0% |
| Gonorrhoea |
4.0% |
| Nasopharyngitis |
4.0% |
| Delusion |
3.0% |
| Opportunistic Infection Prophylaxis |
3.0% |
| Infection |
2.5% |
| Fibromyalgia |
2.0% |
| Mycobacterium Avium Complex Infection |
2.0% |
| Obliterative Bronchiolitis |
2.0% |
| Respiratory Tract Infection |
2.0% |
|
| Drug Interaction |
19.6% |
| International Normalised Ratio Increased |
14.3% |
| Penis Disorder |
7.1% |
| Thrombocytopenia |
5.4% |
| Tremor |
5.4% |
| Urinary Tract Infection |
5.4% |
| Drug Level Increased |
3.6% |
| Hallucination, Visual |
3.6% |
| Hypoglycaemia |
3.6% |
| Muscle Disorder |
3.6% |
| Nervous System Disorder |
3.6% |
| Rash |
3.6% |
| Renal Failure |
3.6% |
| Renal Failure Acute |
3.6% |
| Sinusitis |
3.6% |
| Upper Respiratory Tract Infection |
3.6% |
| Cerebral Haemorrhage Traumatic |
1.8% |
| Drug Toxicity |
1.8% |
| Electrocardiogram Qt Prolonged |
1.8% |
| Hypersensitivity |
1.8% |
|
